Welcome to LookChem.com Sign In|Join Free
  • or
1,4-Naphthalenedione, 2-[(4-aminophenyl)amino]-3-chloro-, also known as CI Direct Black 38 or Direct Black 38, is an organic compound primarily used as a dye in the textile industry. It is a dark black powder with the chemical formula C16H12ClN3O2. 1,4-Naphthalenedione, 2-[(4-aminophenyl)amino]-3-chloro- is characterized by its ability to form a complex with cellulose fibers, providing a deep black color. It is synthesized through a series of chemical reactions involving naphthalene and aniline derivatives. Due to its potential health and environmental risks, including carcinogenic properties, its use is regulated in many countries, and safer alternatives are often sought for applications involving direct contact with the skin or the environment.

92796-77-5

Post Buying Request

92796-77-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

92796-77-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 92796-77-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,7,9 and 6 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 92796-77:
(7*9)+(6*2)+(5*7)+(4*9)+(3*6)+(2*7)+(1*7)=185
185 % 10 = 5
So 92796-77-5 is a valid CAS Registry Number.

92796-77-5Relevant academic research and scientific papers

COMPOUNDS AND PHARMACEUTICAL COMPOSITION ASSOCIATED WITH UBIQUITINATION-PROTEASOME SYSTEM

-

Paragraph 18, (2018/06/01)

The invention relates to new compounds with low cytotoxicity for blocking ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of treating disorders including, but not limited to, cancers, neurodegenerative d

Identification of compounds for the treatment or prevention of proliferative diseases

-

Page 20, 21, 22, (2010/02/03)

The invention features compounds for the treatment of cancer and other proliferative diseases. These compounds were identified in screening assays that contact candidate compounds with a cell containing a nucleic acid that includes a HER2 regulatory element and a reporter sequence. The invention further features compounds structurally related to those identified by the screening assays. Finally, the invention features methods of treating or preventing a proliferative disease using the compounds of the invention.

Identification of compounds for the treatment or prevention of proliferative diseases

-

, (2008/06/13)

The invention features screening assays for compounds that are potentially useful for treating or preventing a proliferative disease. The assays are based on contacting a candidate compound with a cell containing a nucleic acid including a HER2 regulatory element and a reporter sequence. In addition, the invention features compounds identified by the assays of the invention. The invention further features compounds structurally related to those identified by the screening assays. Finally, the invention features methods of treating or preventing a proliferative disease using the compounds of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 92796-77-5